Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Finasterida")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 325

  • Page / 13
Export

Selection :

  • and

Determination of finasteride in the tablet form by liquid chromatography and its analytical method validationDEMIR, Hulya; CUCU, Aysen; SAKARYA, Serap et al.Analytica chimica acta. 2006, Vol 557, Num 1-2, pp 252-255, issn 0003-2670, 4 p.Article

Finasteride treatment of female pattern hair lossIORIZZO, Matilde; VINCENZI, Colombina; VOUDOURIS, Stylianos et al.Archives of dermatology (1960). 2006, Vol 142, Num 3, pp 298-302, issn 0003-987X, 5 p.Article

Finasteride improves male pattern hair loss in a randomized study in identical twinsSTOUGH, Dow B; RAO, Naveen A; KAUFMAN, Keith D et al.EJD. European journal of dermatology. 2002, Vol 12, Num 1, pp 32-37, issn 1167-1122Article

Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia A Systematic ReviewMELLA, Jose Manuel; PERRET, Maria Clara; MANZOTTI, Matias et al.Archives of dermatology (1960). 2010, Vol 146, Num 10, pp 1141-1150, issn 0003-987X, 10 p.Article

Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasiaMAGOHA, G. A. O.East African medical journal. 1998, Vol 75, Num 5, pp 260-263, issn 0012-835XArticle

Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placeboOLSEN, Elise A; WHITING, David A; SAVIN, Ronald et al.Journal of the American Academy of Dermatology. 2012, Vol 67, Num 3, pp 379-386, issn 0190-9622, 8 p.Article

GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteridePIERUCCI-LAGHA, Amira; COVAULT, Jonathan; FEINN, Richard et al.Neuropsychopharmacology (New York, NY). 2005, Vol 30, Num 6, pp 1193-1203, issn 0893-133X, 11 p.Article

Finasteride in the treatment of men with androgenetic alopeciaKAUFMAN, K. D; OLSEN, E. A; SHAPIRO, J et al.Journal of the American Academy of Dermatology. 1998, Vol 39, Num 4, pp 578-589, issn 0190-9622, 1Article

Finasteride increases anagen hair in men with androgenetic alopeciaVAN NESTE, D; FUH, V; TOSTI, A et al.British journal of dermatology (1951). 2000, Vol 143, Num 4, pp 804-810, issn 0007-0963Article

Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair lossROBERTS, J. L; FIEDLER, V; BERGFELD, W et al.Journal of the American Academy of Dermatology. 1999, Vol 41, Num 4, pp 555-563, issn 0190-9622Article

Improvement in androgenetic alopecia in 53-76-year-old men using oral finasterideBRENNER, S; MATZ, H.International journal of dermatology. 1999, Vol 38, Num 12, pp 928-930, issn 0011-9059Article

Long-Term Effects of Doxazosin, Finasteride and Combination Therapy on Quality of Life in Men with Benign Prostatic HyperplasiaFWU, Chyng-Wen; EGGERS, Paul W; KAPLAN, Steven A et al.The Journal of urology. 2013, Vol 190, Num 1, pp 187-193, issn 0022-5347, 7 p.Article

Alteration of neonatal Allopregnanolone levels affects exploration, anxiety, aversive learning and adult behavioural response to intrahippocampal neurosteroidsMODOL, Laura; DARBRA, Sònia; VALLEE, Monique et al.Behavioural brain research. 2013, Vol 241, pp 96-104, issn 0166-4328, 9 p.Article

Inhibiteurs des 5 alpha-réductases et cancer de la prostate: une mise au point du Comité de cancérologie de l'Association française d'urologie = 5 alpha-reductase inhibitors and prostate cancer: A statement of the Committee of Cancerology of the French Association of UrologyESCHWEGE, P; GASCHIGNARD, N; RENARD-PENNA, R et al.Progrès en urologie (Paris). 2012, Vol 22, Num 10, pp 555-560, issn 1166-7087, 6 p.Article

Allopregnanolone and Induction of Endogenous Opioid Inhibition of Oxytocin Responses to Immune Stress in Pregnant RatsBRUNTON, P. J; BALES, J; RUSSELL, J. A et al.Journal of neuroendocrinology. 2012, Vol 24, Num 4, pp 690-700, issn 0953-8194, 11 p.Article

Synthesis and bioactivity of new Finasteride conjugateZHAO SHUANG; WU JIAZHEN; YANG LIJUAN et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 11, pp 3439-3442, issn 0960-894X, 4 p.Article

Interaction between early postnatal neurosteroid manipulations and adult infusion of neurosteroids into CA1 hippocampal region on the open field behaviourDARBRA, Sònia; PALLARES, Marc.Behavioural brain research. 2011, Vol 216, Num 2, pp 705-711, issn 0166-4328, 7 p.Article

Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH : Management of BPH in 2010 (Treatment)GRAVAS, Stavros; OELKE, Matthias.World journal of urology (Print). 2010, Vol 28, Num 1, pp 9-15, issn 0724-4983, 7 p.Article

Hydrophobic solvent induced phase transition extraction to extract drugs from plasma for high performance liquid chromatography-mass spectrometric analysisGUOZHU LIU; NAIYUAN ZHOU; MINGSHAN ZHANG et al.Journal of chromatography. 2010, Vol 1217, Num 3, pp 243-249, issn 0021-9673, 7 p.Article

Efficacité de la doxazosine, du finastéride et d'un traitement combiné sur la nycturie chez les hommes atteints d'hyperplasie bénigne de la prostate = Effectiveness of doxazosin, finasteride and combined treatment on nocturia in men with benign prostatic hyperplasiaPIAU, A.Les Cahiers de l'année gérontologique (Imprimé). 2010, Vol 2, Num 3, pp 163-165, issn 1760-5342, 3 p.Article

Binary and ternary inclusion complexes of finasteride in HPβCD and polymers : Preparation and characterizationASBAHR, Ana Carolina C; FRANCO, Luzia; BARISON, Andersson et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 7, pp 2718-2723, issn 0968-0896, 6 p.Article

Bioequivalence of a Single 10-mg Dose of Finasteride 5-mg Oral Disintegrating Tablets and Standard Tablets in Healthy Adult Male Han Chinese Volunteers: A Randomized Sequence, Open-Label, Two-Way Crossover StudyLI CHEN; XUEHUA JIANG; LIANG HUANG et al.Clinical therapeutics. 2009, Vol 31, Num 10, pp 2242-2248, issn 0149-2918, 7 p.Article

Pharmacological Approaches to Reducing the Risk of Prostate Cancer. CommentariesRITTMASTER, Roger S; FLESHNER, Neil E; THOMPSON, Ian M et al.European urology. 2009, Vol 55, Num 5, pp 1064-1074, issn 0302-2838, 11 p.Article

Traitement médical de l'hyperplasie bénigne de prostate = Medical treatment of BPHDESCAZEAUD, A.Progrès en urologie (Paris). 2009, Vol 19, Num 12, pp 890-892, issn 1166-7087, 3 p.Article

Finastéride pour la prévention du cancer de la prostate = Finasteride to prevent prostate cancerThe Medical letter on drugs and therapeutics (Edition française). 2008, Vol 30, Num 15, pp 57-58, issn 0253-8512, 2 p.Article

  • Page / 13